HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

RAS and RHO family GTPase mutations in cancer: twin sons of different mothers?

Abstract
The RAS and RHO family comprise two major branches of the RAS superfamily of small GTPases. These proteins function as regulated molecular switches and control cytoplasmic signaling networks that regulate a diversity of cellular processes, including cell proliferation and cell migration. In the early 1980s, mutationally activated RAS genes encoding KRAS, HRAS and NRAS were discovered in human cancer and now comprise the most frequently mutated oncogene family in cancer. Only recently, exome sequencing studies identified cancer-associated alterations in two RHO family GTPases, RAC1 and RHOA. RAS and RHO proteins share significant identity in their amino acid sequences, protein structure and biochemistry. Cancer-associated RAS mutant proteins harbor missense mutations that are found primarily at one of three mutational hotspots (G12, G13 and Q61) and have been identified as gain-of-function oncogenic alterations. Although these residues are conserved in RHO family proteins, the gain-of-function mutations found in RAC1 are found primarily at a distinct hotspot. Unexpectedly, the cancer-associated mutations found with RHOA are located at different hotspots than those found with RAS. Furthermore, since the RHOA mutations suggested a loss-of-function phenotype, it has been unclear whether RHOA functions as an oncogene or tumor suppressor in cancer development. Finally, whereas RAS mutations are found in a broad spectrum of cancer types, RHOA and RAC1 mutations occur in a highly restricted range of cancer types. In this review, we focus on RHOA missense mutations found in cancer and their role in driving tumorigenesis, with comparisons to cancer-associated mutations in RAC1 and RAS GTPases.
AuthorsRichard G Hodge, Antje Schaefer, Sarah V Howard, Channing J Der
JournalCritical reviews in biochemistry and molecular biology (Crit Rev Biochem Mol Biol) Vol. 55 Issue 4 Pg. 386-407 (08 2020) ISSN: 1549-7798 [Electronic] England
PMID32838579 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Review, Video-Audio Media)
Chemical References
  • RAC1 protein, human
  • RHOA protein, human
  • Proto-Oncogene Proteins p21(ras)
  • rac1 GTP-Binding Protein
  • rhoA GTP-Binding Protein
Topics
  • Animals
  • Carcinogenesis (genetics, metabolism, pathology)
  • Cell Movement
  • Cell Proliferation
  • Gain of Function Mutation
  • Humans
  • Loss of Function Mutation
  • Proto-Oncogene Proteins p21(ras) (genetics, metabolism)
  • rac1 GTP-Binding Protein (genetics, metabolism)
  • rhoA GTP-Binding Protein (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: